TGFB1 and chronic kidney disease: Thus, these findings support the notion that the overactive TGF-β signaling in injured kidneys promotes EndMT and peritubular capillary rarefaction mediated by Smad2/3 activation to promote inflammation and fibrosis development in CKD.